For decades, recurrent vulvovaginal Candidiasis (RVVC) has been a poorly managed disease and has been a  neglected infectious disease leaving over 100 million women worldwide with ineffective treatment options.

​

Nipple thrush, caused by Candida yeast infections, affects about one-third of nursing women, causing intense pain, burning, or shooting pain. Over ten percent of women seek treatment. Current treatments have been reported to cause nipple ulceration and mouth ulcers in the infant. Treatments in some instances have been reported to worsen the symptoms. More effective and safe treatment options for women are needed.

​

Thanks to years of groundbreaking research, our lead asset is poised to provide a first-in-class solutions for these fungal infections.